Advertisement

Journal of Neural Transmission

, Volume 113, Issue 3, pp 331–337 | Cite as

Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson’s disease

  • G. Gossrau
  • B. Herting
  • S. Möckel
  • A. Kempe
  • R. Koch
  • H. Reichmann
  • J. B. Lampe
Article

Summary.

Idiopathic Parkinson’s disease (IPD) is a neurodegenerative disorder of unknown aetiology. Histopathological similarities between IPD and Creutzfeldt-Jakob prion disease (CJD) have been suggested. Homozygosity at polymorphic prion protein gene codon 129 (PRNP129) is a risk factor for developing CJD. Therefore we investigated a putative genetic link between CJD and IPD by studying PRNP129 genotype segregation in 81 patients with IPD.

We did not ascertain a different PRNP129 genotype distribution in IPD patients compared to healthy Germans. We found a significant difference in PRNP129 genotype in dependence of the clinical predominance type of IPD. Patients with tremor-dominant IPD presented less frequent a methionine homozygosis at PRNP129 than hypokinetic-rigid IPD patients (30% versus 62.5%; p < 0.033).

In conclusion, genotype distribution at codon 129 is obviously not essential in determining IPD. But our results may provide first evidence of an association between certain PRNP129 polymorphisms and the clinical presentation of IPD.

Keywords: Parkinson’s disease, neurogenetics, Creutzfeldt-Jakob disease, prion disease, codon 129. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alperovitch, A, Zerr, I, Pocchiari, M, Mitrova, E, de Pedro Cuesta, J, Hegyi, I, Collins, S, Kretzschmar, H, van Duijn, C, Will, RG 1999Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease.Lancet35316731674CrossRefPubMedGoogle Scholar
  2. Berr, C, Richard, F, Dufouil, C, Amant, C, Alperovitch, A, Amouyel, P 1998Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study.Neurology51734737PubMedGoogle Scholar
  3. Berr, C, Helbecque, N, Sazdovitch, V, Mohr, M, Amant, C, Amouyel, P, Alperovitch, A, Hauw, JJ 2003Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing.Acta Neuropathol (Berl)1067174Google Scholar
  4. Caughey, B 2003Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.Br Med Bull66109120PubMedGoogle Scholar
  5. Conway, KA, Baxter, EW, Felsenstein, KM, Reitz, AB 2003Emerging beta-amyloid therapies for the treatment of Alzheimer’s disease.Curr Pharm Des9427447CrossRefPubMedGoogle Scholar
  6. Deslys, JP, Marce, D, Dormont, D 1994Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease.J Gen Virol752327PubMedGoogle Scholar
  7. EUROCJD Group2001Genetic epidemiology of Creutzfeldt-Jakob disease in Europe.Rev Neurol (Paris)157633637Google Scholar
  8. Gilks, WP, Abou-Sleiman, PM, Gandhi, S, Jain, S, Singleton, A, Lees, AJ, Shaw, K, Bhatia, KP, Bonifati, V, Quinn, NP, Lynch, J, Healy, DG, Holton, JL, Revesz, T, Wood, NW 2005A common LRRK2 mutation in idiopathic Parkinson’s disease.Lancet365415416PubMedGoogle Scholar
  9. Glatzel, M, Abela, E, Maissen, M, Aguzzi, A 2003Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.N Engl J Med34918121820CrossRefPubMedGoogle Scholar
  10. Gossrau, G, Herting, B, Sommer, U, Füssel, M, Koch, R, Reichmann, H, Lampe, JB 2002HLA and Parkinson’s disease.Ann Neurol5257Google Scholar
  11. Haik, S, Privat, N, Adjou, KT, Sazdovitch, V, Dormont, D, Duyckaerts, C, Hauw, JJ 2002Alpha-synuclein-immunoreactive deposits in human and animal prion diseases.Acta Neuropathol (Berl)103516520Google Scholar
  12. Hauw, JJ, Sazdovitch, V, Laplanche, JL, Peoc’h, K, Kopp, N, Kemeny, J, Privat, N, Delasnerie-Laupretre, N, Brandel, JP, Deslys, JP, Dormont, D, Alperovitch, A 2000Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene.Neurology5416411646PubMedGoogle Scholar
  13. Healy, DG, Abou-Sleiman, PM, Wood, NW 2004Genetic causes of Parkinson’s disease: UCHL-1.Cell Tissue Res318189194CrossRefPubMedGoogle Scholar
  14. Hoehn, MM, Yahr, MD 1967Parkinsonism: onset, progression and mortality.Neurology17427442PubMedGoogle Scholar
  15. Hoehn, MM, Yahr, MD 1967, 2001Parkinsonism: onset, progression and mortality.Neurology57S11S26PubMedGoogle Scholar
  16. Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ 1992Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases.J Neurol Neurosurg Psychiatry55181184PubMedGoogle Scholar
  17. Hughes, AJ, Daniel, SE, Blankson, S, Lees, AJ 1993A clinicopathological study of 100 cases of Parkinson’s disease.Arch Neurol50140148PubMedGoogle Scholar
  18. Hughes, AJ, Daniel, SE, Ben-Shlomo, Y, Lees, AJ 2002The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.Brain125861870CrossRefPubMedGoogle Scholar
  19. Jendroska, K, Hoffmann, O, Schelosky, L, Lees, AJ, Poewe, W, Daniel, SE 1994Absence of disease related prion protein in neurodegenerative disorders presenting with Parkinson’s syndrome.J Neurol Neurosurg Psychiatry5712491251PubMedGoogle Scholar
  20. Kovacs, GG, Zerbi, P, Voigtländer, T, Strohschneider, M, Trabattoni, G, Hainfeller, JA, Budka, H 2002The prion protein in human neurodegenerative disorders.Neurosci Lett329269272CrossRefPubMedGoogle Scholar
  21. Lampe, J, Kitzler, H, Walter, MC, Lochmüller, H, Reichmann, H 1999Methionine homozygousity at prion gene codon 129 may predispose to sporadic inclusion body myositis.Lancet353465466CrossRefPubMedGoogle Scholar
  22. Lampe, JB, Goßrau, G, Herting, B, Kempe, A, Sommer, U, Füssel, M, Weber, M, Koch, R, Reichmann, H 2003HLA Typing and Parkinson’s disease.Eur Neurol506468CrossRefPubMedGoogle Scholar
  23. Laplanche, JL, Delasnerie-Laupetre, N, Brandel, JP, Chatelain, J, Beaudry, P, Alperovitch, A, Launay, JM 1994Molecular genetics from prion disease in France.Neurology4423472351PubMedGoogle Scholar
  24. MacDonald, ST, Sutherland, K, Ironside, JW 1996Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease.Neuropathol Appl Neurobiol22285292PubMedGoogle Scholar
  25. Owen, F, Poulter, M, Collinge, J, Leach, M, Shah, T, Lofthouse, R, Chen, YF, Crow, TJ, Harding, AE, Hardy, J,  et al. 1991Insertions in the prion protein gene in atypical dementias.Exp Neurol112240242CrossRefPubMedGoogle Scholar
  26. Pan, KM, Baldwin, M, Nguyen, J, Gasset, M, Serban, A, Groth, D, Mehlhorn, I, Huang, Z, Fletterick, RJ, Cohen, FE 1993Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.Proc Natl Acad Sci USA901096210966PubMedGoogle Scholar
  27. Parchi, P, Castellani, R, Capellari, S, Ghetti, B, Young, K, Chen, SG, Farlow, M, Dickson, DW, Sima, AA, Trojanowski, JQ, Petersen, RB, Gambetti, P 1996Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.Ann Neurol39767778CrossRefPubMedGoogle Scholar
  28. Rachidi, W, Vilette, D, Guiraud, P, Arlotto, M, Riondel, J, Laude, H, Lehmann, S, Favier, A 2003Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery.J Biol Chem27890649072CrossRefPubMedGoogle Scholar
  29. Roucou, X, Gains, M, LeBlanc, AC 2004Neuroprotective functions of prion protein.J Neurosci Res75153161CrossRefPubMedGoogle Scholar
  30. Schulz-Schaeffer, WJ, Giese, A, Windl, O, Kretzschmar, HA 1996Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeld-Jakob disease.Clin Neuropathol15353357PubMedGoogle Scholar
  31. Singleton, AB, Farrer, M, Johnson, J, Singleton, A, Hague, S, Kachergus, J, Hulihan, M, Peuralinna, T, Dutra, A, Nussbaum, R, Lincoln, S, Crawley, A, Hanson, M, Maraganore, D, Adler, C, Cookson, MR, Muenter, M, Baptista, M, Miller, D, Blancato, J, Hardy, J, Gwinn-Hardy, K 2003alpha-Synuclein locus triplication causes Parkinson’s disease.Science302841CrossRefPubMedGoogle Scholar
  32. Souza, JM, Giasson, BI, Lee, VM, Ischiropoulos, H 2000Chaperone-like activity of synucleins.FEBS Lett474116119CrossRefPubMedGoogle Scholar
  33. Windl, O, Giese, A, Schulz-Schaeffer, W, Zerr, I, Skworc, K, Arendt, S, Oberdieck, C, Bodemer, M, Poser, S, Kretzschmar, HA 1999Molecular genetics of human prion diseases in Germany.Hum Genet105244252CrossRefPubMedGoogle Scholar
  34. Wong, BS, Pan, T, Liu, T, Li, R, Petersen, RB, Jones, IM, Gambetti, P, Brown, DR, Sy, MS 2000Prion disease: a loss of antioxidant function?Biochem Biophys Res Commun275249252CrossRefPubMedGoogle Scholar
  35. Zanata, SM, Lopes, MH, Mercadante, AF, Hajj, GN, Chiarini, LB, Nomizo, R, Freitas, AR, Cabral, AL, Lee, KS, Juliano, MA, de Oliveira, E, Jachieri, SG, Burlingame, A, Huang, L, Linden, R, Brentani, RR, Martins, VR 2002Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection.EMBO J2133073316CrossRefPubMedGoogle Scholar
  36. Zimprich, A, Muller-Myhsok, B, Farrer, M, Leitner, P, Sharma, M, Hulihan, M, Lockhart, P, Strongosky, A, Kachergus, J, Calne, DB, Stoessl, J, Uitti, RJ, Pfeiffer, RF, Trenkwalder, C, Homann, N, Ott, E, Wenzel, K, Asmus, F, Hardy, J, Wszolek, Z, Gasser, T 2004The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.Am J Hum Genet741119CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • G. Gossrau
    • 1
  • B. Herting
    • 1
  • S. Möckel
    • 1
  • A. Kempe
    • 1
  • R. Koch
    • 2
  • H. Reichmann
    • 1
  • J. B. Lampe
    • 1
  1. 1.Department of NeurologyUniversity of TechnologyDresdenGermany
  2. 2.Institute of Biomathematics, University of TechnologyDresdenGermany

Personalised recommendations